Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SLC16A13 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC16A13 mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of SLC16A13 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SLC16A13 mRNA | CTD | PMID:22206623 | 2,3',4,4',5-Pentachlorobiphenyl | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC16A13 mRNA | CTD | PMID:21215274 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC16A13 mRNA | CTD | PMID:28922406 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC16A13 mRNA | CTD | PMID:21570461 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:23196670 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SLC16A13 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC16A13 mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | increases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of SLC16A13 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of SLC16A13 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SLC16A13 mRNA | CTD | PMID:22100608 | amitrole | increases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of SLC16A13 mRNA | CTD | PMID:30047161 | aristolochic acid A | decreases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SLC16A13 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases methylation | ISO | SLC16A13 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SLC16A13 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SLC16A13 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | ISO | SLC16A13 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of SLC16A13 exon | CTD | PMID:27901495 | bisphenol A | affects expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of SLC16A13 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC16A13 mRNA | CTD | PMID:34585602 | bisphenol A | increases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SLC16A13 mRNA | CTD | PMID:32145629 | bisphenol A | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC16A13 mRNA | CTD | PMID:30816183 and PMID:34947998 | bisphenol A | increases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SLC16A13 mRNA | CTD | PMID:27685785 and PMID:29275510 | bisphenol F | multiple interactions | ISO | SLC16A13 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC16A13 mRNA | CTD | PMID:28628672 | CGP 52608 | multiple interactions | ISO | SLC16A13 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLC16A13 gene] | CTD | PMID:28238834 | cisplatin | multiple interactions | ISO | SLC16A13 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SLC16A13 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of SLC16A13 mRNA | CTD | PMID:24386269 | decabromodiphenyl ether | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in decreased expression of SLC16A13 mRNA | CTD | PMID:23640034 | dexamethasone | multiple interactions | ISO | SLC16A13 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC16A13 mRNA | CTD | PMID:28628672 | diazinon | increases methylation | ISO | SLC16A13 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of SLC16A13 gene | CTD | PMID:22964155 | dichloroacetic acid | increases expression | EXP | | 6480464 | Dichloroacetic Acid results in increased expression of SLC16A13 mRNA | CTD | PMID:28962523 | diuron | increases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Diuron results in increased expression of SLC16A13 mRNA | CTD | PMID:21551480 and PMID:25152437 | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of SLC16A13 mRNA | CTD | PMID:35436446 | fenofibrate | increases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | Fenofibrate results in increased expression of SLC16A13 mRNA | CTD | PMID:25572481 | fenvalerate | increases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of SLC16A13 mRNA | CTD | PMID:30307764 | fipronil | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of SLC16A13 mRNA | CTD | PMID:23962444 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of SLC16A13 mRNA | CTD | PMID:25629700 | gentamycin | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SLC16A13 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | ISO | SLC16A13 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC16A13 mRNA | CTD | PMID:28628672 | iron dichloride | decreases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of SLC16A13 mRNA | CTD | PMID:35984750 | leflunomide | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | leflunomide results in decreased expression of SLC16A13 mRNA | CTD | PMID:24136188 | methamphetamine | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Methamphetamine results in decreased expression of SLC16A13 mRNA | CTD | PMID:19564919 | methamphetamine | multiple interactions | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC16A13 mRNA | CTD | PMID:19564919 | methimazole | increases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of SLC16A13 mRNA | CTD | PMID:30047161 | nickel sulfate | increases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of SLC16A13 mRNA | CTD | PMID:22714537 | ochratoxin A | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | ochratoxin A results in decreased expression of SLC16A13 mRNA | CTD | PMID:18417182 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SLC16A13 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of SLC16A13 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SLC16A13 mRNA | CTD | PMID:29067470 | perfluorooctanoic acid | increases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of SLC16A13 mRNA | CTD | PMID:32588087 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC16A13 mRNA | CTD | PMID:18489776 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of SLC16A13 mRNA | CTD | PMID:18301758 and PMID:23811191 | potassium chromate | multiple interactions | ISO | SLC16A13 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC16A13 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SLC16A13 mRNA | CTD | PMID:22079256 | quercitrin | decreases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | quercitrin results in decreased expression of SLC16A13 mRNA | CTD | PMID:25193878 | SCH 23390 | multiple interactions | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC16A13 mRNA | CTD | PMID:19564919 | Soman | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of SLC16A13 mRNA | CTD | PMID:19281266 | sulfadimethoxine | increases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of SLC16A13 mRNA | CTD | PMID:30047161 | sunitinib | increases expression | ISO | SLC16A13 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SLC16A13 mRNA | CTD | PMID:31533062 | thioacetamide | decreases expression | ISO | Slc16a13 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of SLC16A13 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of SLC16A13 mRNA | CTD | PMID:29264374 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SLC16A13 mRNA | CTD | PMID:25549359 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SLC16A13 mRNA | CTD | PMID:19136453 | |